Clinical evidence versus patients' perception of coronary revascularization

Michio Kawasuji1

  • 1Department of Cardiovascular Surgery, Postgraduate School of Medical Sciences, Kumamoto University, Honjo 1-1-1, Chuo-ku, Kumamoto 860-8556, Japan. kawasuji@kumamoto-u.ac.jp

Surgery Today
|January 4, 2013
PubMed

Insights

Coronary artery bypass grafting (CABG) shows better survival than percutaneous coronary intervention (PCI) for complex coronary artery disease. Patients need unbiased information on revascularization risks and benefits from a Heart Team.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Coronary artery disease (CAD) is treated with coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI).
  • CABG offers survival benefits for high-risk patients, while PCI is less invasive and frequently used for multi-vessel disease.
  • PCI has shown no additional benefit over medical therapy regarding myocardial infarction (MI) or death.

Purpose of the Study:

  • To compare the 4-year outcomes of CABG versus PCI with drug-eluting stents in patients with left main and/or three-vessel coronary artery disease.
  • To evaluate all-cause mortality and cardiac death between the two revascularization strategies.

Main Methods:

  • The SYNTAX trial prospectively compared CABG and PCI outcomes.
  • Included patients had left main and/or three-vessel coronary artery disease.
  • Outcomes were assessed over a 4-year follow-up period.

Main Results:

  • All-cause mortality was significantly higher in the PCI group compared to the CABG group.
  • Cardiac death rates were also significantly higher in the PCI group than in the CABG group.
  • Despite evidence, PCI is often recommended over CABG, contrary to guidelines.

Conclusions:

  • CABG demonstrates a survival advantage over PCI in patients with complex coronary artery disease (left main and/or three-vessel disease).
  • PCI is frequently recommended more often than indicated, potentially leading to suboptimal patient outcomes.
  • An informed consent process, facilitated by a Heart Team, is crucial for patients undergoing revascularization for coronary artery disease.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...